Metabolic syndrome is not a single disease. It's a cluster of five interconnected risk factors that, when they occur together, dramatically increase your risk of heart attack, stroke, type 2 diabetes, and premature death. About 35% of US adults meet the criteria. Many don't know it.
The five criteria
You have metabolic syndrome if you meet three or more of these five criteria:
- Waist circumference: ≥102 cm in men, ≥88 cm in women (US/European thresholds)
- Triglycerides: ≥150 mg/dL (or on medication for elevated triglycerides)
- HDL cholesterol: <40 mg/dL in men, <50 mg/dL in women
- Blood pressure: ≥130/85 mmHg (or on antihypertensive medication)
- Fasting glucose: ≥100 mg/dL (or on medication for elevated glucose)
Each of these, individually, is a risk factor. But together they're more than the sum of their parts. Metabolic syndrome roughly doubles your cardiovascular risk and increases your diabetes risk fivefold compared to having none of the criteria.
Why it matters more than individual numbers
The power of the metabolic syndrome diagnosis is pattern recognition. A fasting glucose of 105, triglycerides of 170, HDL of 38, and a waist circumference of 106 cm — each of these is "borderline" individually. None would trigger aggressive treatment on its own. But together, they form a pattern that says: this person has insulin resistance, and their cardiovascular clock is ticking faster than their individual numbers suggest.
The underlying driver, in most cases, is insulin resistance. The visceral fat around your organs produces inflammatory cytokines, disrupts lipid metabolism, raises blood pressure, and eventually overwhelms the pancreas's ability to compensate. Metabolic syndrome is, in many ways, the external manifestation of what HOMA-IR measures internally.
A patient with metabolic syndrome and "borderline" numbers everywhere is at higher risk than a patient with one dramatically elevated number and everything else normal. The pattern matters more than any single value.
Why standard check-ups miss it
The metabolic syndrome diagnosis requires measuring all five components and interpreting them as a cluster. Most standard check-ups measure blood pressure and fasting glucose — but they may not measure triglycerides and HDL (some panels only include total cholesterol), they rarely measure waist circumference, and even when all values are available, the physician may look at each one individually and say "everything's borderline but fine" rather than recognizing the pattern.
What we do at Health Detectors
All five metabolic syndrome criteria are captured in our DETECT assessment — plus HOMA-IR, which detects the underlying insulin resistance even earlier. Waist circumference is measured during the Day 1 clinical exam. The BIA body composition analysis adds visceral fat estimation, which correlates closely with metabolic risk.
If three or more criteria are met — or if HOMA-IR is elevated even without meeting formal metabolic syndrome criteria — the METABOLIC module is activated: abdominal ultrasound (to assess liver fat), DEXA (for precise body composition and visceral fat), and an extended lipid panel. The closing risk report includes a structured intervention plan targeting the specific abnormalities identified.
The good news
Metabolic syndrome is almost entirely reversible with lifestyle intervention — if caught early enough. The Diabetes Prevention Program showed that moderate weight loss (7%) and 150 minutes of weekly exercise reduced progression to diabetes by 58% in people with prediabetes. Similar magnitude improvements in triglycerides, HDL, blood pressure, and waist circumference are well-documented with the same intervention. The hard part isn't the treatment — it's knowing you need it.
References
- Alberti KGMM, et al. Harmonizing the metabolic syndrome (IDF/AHA/NHLBI joint statement). Circulation. 2009;120(16):1640-1645.
- Mottillo S, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113-1132.
- Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes. N Engl J Med. 2002;346:393-403.